{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:15:39Z","timestamp":1776323739651,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd013113","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000}}],"reference-count":107,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013113.pub2","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T07:30:38Z","timestamp":1598427038000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Proton pump inhibitors for chronic obstructive pulmonary disease"],"prefix":"10.1002","volume":"2020","author":[{"given":"Shino","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology; Kyoto University Graduate School of Medicine; Kyoto Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hissei","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Human Behavior; Kyoto University Graduate School of Medicine\/School of Public Health; Kyoto Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Tani","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine; Graduate School of Medicine,Osaka City University; Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Tajiri","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Allergy and Clinical Immunology; Graduate School of Medical Sciences, Nagoya City University; Nagoya Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Human Behavior; Kyoto University School of Public Health; Kyoto Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"key":"10.1002\/14651858.CD013113.pub2-BIB0001|cit1","unstructured":"Sasaki T Katsutoshi N Hiroyasu Y Toshihiro N Mutsuo Y The proton pump inhibitor, lansoprazole, reduces frequency of exacerbations in patients with chronic obstructive pulmonary disease Chest 2011 Annual Meeting; 2011 Oct 22-26; Honolulu 2011"},{"issue":"8","key":"10.1002\/14651858.CD013113.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1532-5415.2009.02349.x","article-title":"A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients","volume":"57","author":"Sasaki","year":"2009","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0003|cit3","unstructured":"Sasaki T Nakayama K Yasuda H Yoshida M Inoue D Yamaya M A proton pump inhibitor lansoprazole reduces frequency of exacerbations in patients with chronic obstructive pulmonary disease (COPD) American Thoracic Society International Conference; 2008 May 16-21; Toronto 2008"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0004|cit4","unstructured":"Sasaki T Nakayama K Yasuda H Yoshida M Inoue D Yamaya M The proton pump inhibitor, lansoprazole, reduces frequency of exacerbations in patients with chronic obstructive pulmonary disease Chest 2011 Annual Meeting; 2011 Oct 22-26; Honolulu 2011"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"A3 (A1","DOI":"10.1016\/0300-2977(95)96955-H","article-title":"Effect of high-dose omeprazole on airway hyperresponsiveness and pulmonary function in patients with obstructive lung disease","volume":"47","author":"Boeree","year":"1995","journal-title":"Netherlands Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD013113.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1183\/09031936.98.11051070","article-title":"No effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a)symptomatic gastro-oesophageal reflux","volume":"11","author":"Boeree","year":"1998","journal-title":"European Respiratory Journal"},{"issue":"4","key":"10.1002\/14651858.CD013113.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1034\/j.1399-3003.2000.16d11.x","article-title":"Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole","volume":"16","author":"Kiljander","year":"2000","journal-title":"European Respiratory Journal"},{"issue":"6","key":"10.1002\/14651858.CD013113.pub2-BIB0008|cit8","first-page":"5528","article-title":"Assessment of anti-reflux treatment on pulmonary ventilation function and inflammatory cytokines in patients with stable chronic obstructive pulmonary disease combined with gastroesophageal reflux","volume":"15","author":"Liu","year":"2018","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40360-015-0017-x","article-title":"The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) - a selective CXCR2 antagonist - in healthy adult subjects","volume":"16","author":"Miller","year":"2015","journal-title":"BMC Pharmacology and Toxicology"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0010|cit10","unstructured":"Evaluate the effects on asthma control of rabeprazole given twice daily in subjects with asthma clinicaltrials.gov\/ct2\/show\/NCT00214552"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0011|cit11","unstructured":"COPD patients diagnosed with GERD, COPD exacerbations after treatment with high dose PPI (GERD\/COPD) clinicaltrials.gov\/ct2\/show\/NCT00523367"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.11569\/wcjd.v24.i9.1412","article-title":"Clinical efficacy of antireflux therapy combined with tiotropium bromide in COPD patients with GERD","volume":"9","author":"Sun","year":"2016","journal-title":"World Chinese Journal of Digestology"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0013|cit13","unstructured":"Effects of rabeprazole on acute exacerbation in chronic obstructive pulmonary disease (COPD) patients with acid reflux symptoms upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000002502"},{"issue":"10","key":"10.1002\/14651858.CD013113.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archinte.160.10.1455","article-title":"Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study","volume":"160","author":"Agrawal","year":"2000","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013113.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"The European Respiratory Journal"},{"issue":"6","key":"10.1002\/14651858.CD013113.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/1756283X16668093","article-title":"Vonoprazan-based therapy for Helicobacter pylori eradication: experience and clinical evidence","volume":"9","author":"Akazawa","year":"2016","journal-title":"Therapeutic Advances in Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD013113.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pharmthera.2005.05.005","article-title":"Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases","volume":"108","author":"Andersson","year":"2005","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2466-13-54","article-title":"Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey","volume":"13","author":"Barnes","year":"2013","journal-title":"BMC Pulmonary Medicine"},{"issue":"7156","key":"10.1002\/14651858.CD013113.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.317.7156.452","article-title":"Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database","volume":"317","author":"Bashford","year":"1998","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD013113.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/resp.12758","article-title":"Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD","volume":"21","author":"Baumeler","year":"2016","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0021|cit21","first-page":"555","article-title":"Lung microbiology and exacerbations in COPD","volume":"7","author":"Beasley","year":"2012","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"3","key":"10.1002\/14651858.CD013113.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.bbrc.2006.04.170","article-title":"Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells","volume":"345","author":"Becker","year":"2006","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD013113.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"93S","DOI":"10.1378\/chest.126.2_suppl_1.93S","article-title":"Similarities and differences in asthma and COPD. The Dutch hypothesis","volume":"126","author":"Bleecker","year":"2004","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD013113.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.15326\/jcopdf.2.2.2014.0149","article-title":"Increased severity and mortality of CAP in COPD: results from the German Competence Network, CAPNETZ","volume":"2","author":"Braeken","year":"2015","journal-title":"Journal of the COPD Foundation"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.2147\/COPD.S138435","article-title":"Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom","volume":"12","author":"Braeken","year":"2017","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"4","key":"10.1002\/14651858.CD013113.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/infdis\/137.4.377","article-title":"Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis","volume":"137","author":"Buscho","year":"1978","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD013113.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1183\/09031936.04.00107004","article-title":"Increased gastro-oesophageal reflux disease in patients with severe COPD","volume":"23","author":"Casanova","year":"2004","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1002\/14651858.CD013113.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/SGA.0000000000000359","article-title":"Gastroesophageal reflux disease: pathophysiology, diagnosis, and treatment","volume":"42","author":"Chen","year":"2019","journal-title":"Gastroenterology Nursing"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0029|cit29","unstructured":"Deeks JJ Higgins JP Altman DG on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD013113.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00003495-200464030-00004","article-title":"The role of proton pump inhibitors in gastro-oesophageal reflux disease","volume":"64","author":"Dekel","year":"2004","journal-title":"Drugs"},{"issue":"1","key":"10.1002\/14651858.CD013113.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11605-015-2955-4","article-title":"Pathophysiology of gastroesophageal reflux in patients with chronic pulmonary obstructive disease Is linked to an increased transdiaphragmatic pressure gradient and not to a defective esophagogastric barrier","volume":"20","author":"Del Grande","year":"2016","journal-title":"Journal of Gastrointestinal Surgery"},{"issue":"6","key":"10.1002\/14651858.CD013113.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"63","author":"El-Serag","year":"2014","journal-title":"Gut"},{"issue":"3","key":"10.1002\/14651858.CD013113.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1503\/cmaj.092129","article-title":"Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis","volume":"183","author":"Eom","year":"2011","journal-title":"Canadian Medical Association Journal"},{"issue":"6","key":"10.1002\/14651858.CD013113.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1164\/rccm.200510-1681OC","article-title":"Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease","volume":"173","author":"Falsey","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013113.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/gutjnl-2013-304738","article-title":"Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis","volume":"63","author":"Filion","year":"2014","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD013113.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD013113.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/1817-1737.53347","article-title":"Pulmonary manifestations of gastroesophageal reflux disease","volume":"4","author":"Gaude","year":"2009","journal-title":"Annals of Thoracic Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013113.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1183\/09031936.00223113","article-title":"Human rhinovirus infection during naturally occurring COPD exacerbations","volume":"44","author":"George","year":"2014","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1002\/14651858.CD013113.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1586\/ecp.12.20","article-title":"Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis","volume":"5","author":"Giuliano","year":"2012","journal-title":"Expert Review of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0040|cit40","unstructured":"Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020 goldcopd.org\/wp-content\/uploads\/2019\/12\/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0041|cit41","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"issue":"9","key":"10.1002\/14651858.CD013113.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/archinte.167.9.950","article-title":"Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study","volume":"167","author":"Gulmez","year":"2007","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2013.12.006","article-title":"Experimental rhinovirus infection in COPD: implications for antiviral therapies","volume":"102","author":"Gunawardana","year":"2014","journal-title":"Antiviral Research"},{"issue":"5","key":"10.1002\/14651858.CD013113.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1164\/rccm.200912-1843CC","article-title":"Chronic obstructive pulmonary disease phenotypes: the future of COPD","volume":"182","author":"Han","year":"2010","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"30","key":"10.1002\/14651858.CD013113.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.3748\/wjg.v16.i30.3745","article-title":"Gastroesophageal reflux disease: from pathophysiology to treatment","volume":"16","author":"Herbella","year":"2010","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0046|cit46","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"8","key":"10.1002\/14651858.CD013113.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"e0183808","DOI":"10.1371\/journal.pone.0183808","article-title":"Risk of pneumonia in patients with gastroesophageal reflux disease: a population-based cohort study","volume":"12","author":"Hsu","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fcimb.2017.00168","article-title":"Novel and effective therapeutic regimens for Helicobacter pylori in an era of increasing antibiotic resistance","volume":"7","author":"Hu","year":"2017","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1038\/ctg.2015.39","article-title":"Potassium-Competitive Acid Blockers (P-CABs): are they finally ready for prime time in acid-related disease?","volume":"6","author":"Hunt","year":"2015","journal-title":"Clinical and Translational Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD013113.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1183\/09031936.05.00043405","article-title":"Epidemiological relationships between the common cold and exacerbation frequency in COPD","volume":"26","author":"Hurst","year":"2005","journal-title":"European Respiratory Journal"},{"issue":"12","key":"10.1002\/14651858.CD013113.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0052|cit52","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Integrated addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2). Current Step 4 version dated 9 November 2016 \/\/database.ich.org\/sites\/default\/files\/E6_R2_Addendum.pdf"},{"issue":"1","key":"10.1002\/14651858.CD013113.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/resp.12420","article-title":"Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease","volume":"20","author":"Ingebrigtsen","year":"2015","journal-title":"Respirology"},{"issue":"23","key":"10.1002\/14651858.CD013113.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM200012073432308","article-title":"The diagnosis and treatment of cough","volume":"343","author":"Irwin","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD013113.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"80S","DOI":"10.1378\/chest.129.1_suppl.80S","article-title":"Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines","volume":"129","author":"Irwin","year":"2006","journal-title":"Chest"},{"issue":"8","key":"10.1002\/14651858.CD013113.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00535-016-1227-8","article-title":"Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015","volume":"51","author":"Iwakiri","year":"2016","journal-title":"Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD013113.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2982.2007.01020.x","article-title":"Acidification of the oesophagus acutely increases the cough sensitivity in patients with gastro-oesophageal reflux and chronic cough","volume":"20","author":"Javorkova","year":"2008","journal-title":"Neurogastroenterology and Motility"},{"issue":"2","key":"10.1002\/14651858.CD013113.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11606-012-2211-5","article-title":"Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia","volume":"28","author":"Jena","year":"2013","journal-title":"Journal of General Internal Medicine"},{"issue":"11","key":"10.1002\/14651858.CD013113.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2036.2010.04284.x","article-title":"Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia","volume":"31","author":"Johnstone","year":"2010","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD013113.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0016-5085(88)90612-9","article-title":"Effect of peristaltic dysfunction on esophageal volume clearance","volume":"94","author":"Kahrilas","year":"1988","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD013113.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"American Journal of Gastroenterology"},{"issue":"16","key":"10.1002\/14651858.CD013113.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jama.292.16.1955","article-title":"Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs","volume":"292","author":"Laheij","year":"2004","journal-title":"Journal of the American Medical Association"},{"issue":"6","key":"10.1002\/14651858.CD013113.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"e0128004","DOI":"10.1371\/journal.pone.0128004","article-title":"Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis","volume":"10","author":"Lambert","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2147\/COPD.S77562","article-title":"Gastroesophageal reflux disease in COPD: links and risks","volume":"10","author":"Lee","year":"2015","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"30","DOI":"10.12688\/f1000research.6085.2","article-title":"Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry","volume":"4","author":"Long","year":"2015","journal-title":"F1000Research"},{"issue":"6","key":"10.1002\/14651858.CD013113.pub2-BIB0066|cit66","first-page":"431","article-title":"The role of the vague nerve in airway narrowing caused by intraesophageal hydrochloric acid provocation and esophageal distention","volume":"47","author":"Mansfield","year":"1981","journal-title":"Annals of Allergy"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1465-9921-15-62","article-title":"Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort","volume":"15","author":"Martinez","year":"2014","journal-title":"Respiratory Research"},{"issue":"5","key":"10.1002\/14651858.CD013113.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/sim.8009","article-title":"Allowing for uncertainty due to missing and LOCF imputed outcomes in meta-analysis","volume":"38","author":"Mavridis","year":"2019","journal-title":"Statistics in medicine"},{"issue":"5","key":"10.1002\/14651858.CD013113.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1183\/09031936.00020811","article-title":"Microbial evaluation of proton-pump inhibitors and the risk of pneumonia","volume":"38","author":"Meijvis","year":"2011","journal-title":"The European Respiratory Journal"},{"issue":"7","key":"10.1002\/14651858.CD013113.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"7","key":"10.1002\/14651858.CD013113.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013113.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1378\/chest.119.4.1043","article-title":"Increased prevalence of gastroesophageal reflux symptoms in patients with COPD","volume":"119","author":"Mokhlesi","year":"2001","journal-title":"Chest"},{"issue":"114","key":"10.1002\/14651858.CD013113.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1183\/09059180.00002509","article-title":"Gastro-oesophageal reflux disease and non-asthma lung disease","volume":"18","author":"Morehead","year":"2009","journal-title":"European Respiratory Review"},{"issue":"8","key":"10.1002\/14651858.CD013113.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1023\/A:1026604203237","article-title":"Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells","volume":"44","author":"Ohara","year":"1999","journal-title":"Digestive Diseases and Sciences"},{"issue":"Suppl 8A","key":"10.1002\/14651858.CD013113.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"174S","DOI":"10.1016\/S0002-9343(01)00828-2","article-title":"Overview of the mechanisms of gastroesophageal reflux","volume":"111","author":"Orlando","year":"2001","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"i5813","DOI":"10.1136\/bmj.i5813","article-title":"Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study","volume":"355","author":"Othman","year":"2016","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD013113.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/00042737-200012080-00002","article-title":"Smoking and gastro-oesophageal reflux disease","volume":"12","author":"Pandolfino","year":"2000","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD013113.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/15412555.2011.650239","article-title":"Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality","volume":"9","author":"Perera","year":"2012","journal-title":"COPD"},{"issue":"7","key":"10.1002\/14651858.CD013113.pub2-BIB0079|cit79","first-page":"276","article-title":"Proportion of gastroesophageal reflux symptoms in patients with chronic obstructive pulmonary disease","volume":"55","author":"Phulpoto","year":"2005","journal-title":"Journal of the Pakistan Medical Association"},{"issue":"13","key":"10.1002\/14651858.CD013113.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJMra1411863","article-title":"The asthma-COPD overlap syndrome","volume":"373","author":"Postma","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013113.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jaci.2015.06.018","article-title":"Revisiting the Dutch hypothesis","volume":"136","author":"Postma","year":"2015","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"10.1002\/14651858.CD013113.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1378\/chest.09-1541","article-title":"Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD","volume":"137","author":"Quint","year":"2010","journal-title":"Chest"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0083|cit83","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"4","key":"10.1002\/14651858.CD013113.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002296","article-title":"Prevention of NSAID-induced gastroduodenal ulcers","author":"Rostom","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2-3","key":"10.1002\/14651858.CD013113.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejphar.2004.12.042","article-title":"The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells","volume":"509","author":"Sasaki","year":"2005","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD013113.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1753465810392264","article-title":"A new strategy with proton pump inhibitors for the prevention of acute exacerbations in COPD","volume":"5","author":"Sasaki","year":"2011","journal-title":"Therapeutic Advances in Respiratory Disease"},{"issue":"3","key":"10.1002\/14651858.CD013113.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1378\/chest.106.3.731","article-title":"Gastroesophageal reflux-induced bronchoconstriction. An intraesophageal acid infusion study using state-of-the-art technology","volume":"106","author":"Schan","year":"1994","journal-title":"Chest"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0088|cit88","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JP Deeks JJ Glasziou P on behalf of the Cochrane Applicability and Recommendations Methods Group Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"11-2","key":"10.1002\/14651858.CD013113.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/apt.13414","article-title":"The binding selectivity of vonoprazan (TAK-438) to the gastric H+, K+ -ATPase","volume":"42","author":"Scott","year":"2015","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD013113.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease","volume":"157","author":"Seemungal","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"22","key":"10.1002\/14651858.CD013113.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMra0800353","article-title":"Infection in the pathogenesis and course of chronic obstructive pulmonary disease","volume":"359","author":"Sethi","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD013113.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/j.1572-0241.2006.00723.x","article-title":"The burden of gastrointestinal and liver diseases, 2006","volume":"101","author":"Shaheen","year":"2006","journal-title":"American Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD013113.pub2-BIB0093|cit93","first-page":"225","article-title":"Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases","volume":"121","author":"Smith","year":"1980","journal-title":"American Review of Respiratory Disease"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1756283X1774577","DOI":"10.1177\/1756283X17745776","article-title":"Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date","volume":"11","author":"Sugano","year":"2018","journal-title":"Therapeutic Advances in Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD013113.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s005350170107","article-title":"Relationship between severity of reflux esophagitis according to the Los Angeles classification and esophageal motility","volume":"36","author":"Sugiura","year":"2001","journal-title":"Journal of Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD013113.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/thx.2007.092858","article-title":"Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation","volume":"63","author":"Terada","year":"2008","journal-title":"Thorax"},{"issue":"4","key":"10.1002\/14651858.CD013113.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0016-5085(84)90082-9","article-title":"Comparison of airway responses following tracheal or esophageal acidification in the cat","volume":"87","author":"Tuchman","year":"1984","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD013113.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus","volume":"101","author":"Vakil","year":"2006","journal-title":"The American Journal of Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD013113.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1525-1497.2003.20833.x","article-title":"Short-term treatment of gastroesophageal reflux disease","volume":"18","author":"Pinxteren","year":"2003","journal-title":"Journal of General Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD013113.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/gut.48.6.774","article-title":"Acid regulates inflammatory response in a rat model of induction of gastric ulcer recurrence by interleukin 1beta","volume":"48","author":"Watanabe","year":"2001","journal-title":"Gut"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1741-7015-11-181","article-title":"Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease","volume":"11","author":"Wedzicha","year":"2013","journal-title":"BMC Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013113.pub2-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"1600791","DOI":"10.1183\/13993003.00791-2016.","article-title":"Management of COPD exacerbations: a European Respiratory Society\/American Thoracic Society guideline","volume":"49","author":"Miravitlles","year":"2017","journal-title":"The European Respiratory Journal"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0103|cit103","unstructured":"World Health Organization Chronic respiratory diseases www.who.int\/respiratory\/en\/"},{"issue":"9979","key":"10.1002\/14651858.CD013113.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(15)60693-6","article-title":"Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management","volume":"385","author":"Woodruff","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD013113.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s12325-017-0532-9","article-title":"A review of the novel application and potential adverse effects of proton pump inhibitors","volume":"34","author":"Yu","year":"2017","journal-title":"Advances in Therapy"},{"key":"10.1002\/14651858.CD013113.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"41021","DOI":"10.1038\/srep41021","article-title":"Effectiveness and tolerability of different recommended doses of PPIs and H2RAs in GERD: network meta-analysis and GRADE system","volume":"7","author":"Zhang","year":"2017","journal-title":"Scientific Reports"},{"issue":"8","key":"10.1002\/14651858.CD013113.pub2-BIB0107|cit107","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013113","article-title":"Proton pump inhibitors for chronic obstructive pulmonary disease","author":"Kikuchi","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T15:04:41Z","timestamp":1723475081000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD013113.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":107,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013113.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,25]]}}}